European Environmentally Related Tax Revenue from Taxes on Energy in Manufacturing of Basic Pharmaceutical Products and Pharmaceutical Preparations Share by Country (Million US Dollars)

The 2023 data highlights France as the leader by a substantial margin in environmentally related tax revenue from energy within the pharmaceutical manufacturing sector, at $37.11 million, followed by Switzerland and the United Kingdom. Positive year-on-year growth was seen in countries like Switzerland, UK, and Romania, while others such as Belgium, Czech Republic, and Bulgaria experienced notable declines. Over the last two years, countries like Lithuania and Malta showed strong percentage growth, indicating their rising focus on energy-related environmental taxation. Bulgaria experienced the largest decline, highlighting potential policy or operational challenges.

Looking ahead, emerging energy policies and international commitments to reduce emissions could spur further growth in environmentally related taxes across Europe. Countries with advancing green technologies and environmental consciousness, like Switzerland and Sweden, might see increased revenue as fiscal policies tighten. Conversely, countries with lesser emphasis might lag, offering limited financial incentives or facing sluggish growth in this sector. Monitoring these dynamics will be pivotal for understanding future shifts in tax revenue attributed to energy consumption in pharmaceutical manufacturing.